Jan Derks
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Recognitions
Jan Derks has a total of 239 co-authors. Here are the top co-authors by number of shared publications:
- Cristiano Tomasi
Department of Periodontology, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
22 shared publications - Tord Berglundh
Department of Periodontology, Institute of Odontology The Sahlgrenska Academy at University of Gothenburg Gothenburg Sweden
22 shared publications - Anna Trullenque‐Eriksson
Department of Periodontology, Institute of Odontology The Sahlgrenska Academy at University of Gothenburg Gothenburg Sweden
12 shared publications - Carlotta Dionigi
Department of Periodontology, Institute of Odontology The Sahlgrenska Academy at University of Gothenburg Gothenburg Sweden
8 shared publications - Filippo Graziani
Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, School of Dentistry University of Pisa Pisa Italy
8 shared publications Jan L. Wennström
Department of Periodontology Institute of Odontology The Sahlgrenska Academy at University of Gothenburg Gothenburg Sweden
8 shared publications
Latest Publications
- 11 October 2026
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 53 (12) , 1867-1877
Microbial Network Signatures Associated With Outcomes of Peri‐Implantitis Therapy
Aim: To investigate the microbial network signatures associated with outcomes following surgical therapy of peri‐implantitis. Materials and Methods: Microbiological data from a 1‐year randomised controlled trial of 28 patients (28 implants) were analysed. Based on a composite outcome (probing depth ≤ 5 mm, minimal bleeding on probing and no further marginal bone loss) at 1 year, implant sites were categorised into a successful ( n = 10) or a non‐successful group ( n = 18). Peri‐implant crevicular fluid was collected at baseline and at 3, 6 and 12 months and analysed using 16S rRNA gene sequencing. Results: A significant compositional shift from baseline to 1 year was observed in the successful group ( p = 0.001), with a significant increase in Rothia aeria ( p = 0.048), Haemophilus parainfluenzae ( p = 0.033) and Neisseria oralis ( p = 0.025) over time. Network analysis revealed that the successful group exhibited a Porphyromonas gingivalis ‐associated module enriched with high‐centrality commensals at baseline, and significantly greater network edge density ( p = 0.005) and connectivity ( p = 0.018) at 1 year. Spearman correlation analyses at 1 year identified significant negative correlations between P. gingivalis and commensals including H. parainfluenzae , Streptococcus species and Veillonella undefined ( p < 0.05). Conclusion: In this exploratory secondary analysis of a small cohort, favourable outcomes of peri‐implantitis therapy were associated with increased microbial network connectivity and commensal centrality. Trial Registration: Korean Clinical Research Information Service number KCT0007900
- 11 October 2026
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 53 (12) , 1867-1877
Microbial Network Signatures Associated With Outcomes of Peri‐Implantitis Therapy
Aim: To investigate the microbial network signatures associated with outcomes following surgical therapy of peri‐implantitis. Materials and Methods: Microbiological data from a 1‐year randomised controlled trial of 28 patients (28 implants) were analysed. Based on a composite outcome (probing depth ≤ 5 mm, minimal bleeding on probing and no further marginal bone loss) at 1 year, implant sites were categorised into a successful ( n = 10) or a non‐successful group ( n = 18). Peri‐implant crevicular fluid was collected at baseline and at 3, 6 and 12 months and analysed using 16S rRNA gene sequencing. Results: A significant compositional shift from baseline to 1 year was observed in the successful group ( p = 0.001), with a significant increase in Rothia aeria ( p = 0.048), Haemophilus parainfluenzae ( p = 0.033) and Neisseria oralis ( p = 0.025) over time. Network analysis revealed that the successful group exhibited a Porphyromonas gingivalis ‐associated module enriched with high‐centrality commensals at baseline, and significantly greater network edge density ( p = 0.005) and connectivity ( p = 0.018) at 1 year. Spearman correlation analyses at 1 year identified significant negative correlations between P. gingivalis and commensals including H. parainfluenzae , Streptococcus species and Veillonella undefined ( p < 0.05). Conclusion: In this exploratory secondary analysis of a small cohort, favourable outcomes of peri‐implantitis therapy were associated with increased microbial network connectivity and commensal centrality. Trial Registration: Korean Clinical Research Information Service number KCT0007900
- 9 September 2026
- Published by Wiley in Journal of Clinical Periodontology
Management of Acute Periodontal Conditions—The EFP S2k Level Clinical Practice Guideline
Background: The European Federation of Periodontology (EFP) has developed Clinical Practice Guidelines (CPGs) for the treatment of periodontitis and for the management of peri‐implant diseases. In accordance with the 2018 Classification, acute periodontal conditions are characterised by rapid‐onset pain or discomfort, tissue destruction and infection. Therefore, the development of a CPG to guide patients and clinicians in their management is justified. Aim: To develop an S2k‐level CPG for the management of acute periodontal conditions, necrotising periodontal diseases, periodontal abscesses and acute manifestations of endodontic–periodontal lesions. Methods: This S2k‐level CPG was developed by the EFP, following methodological guidance from the Association of Scientific Medical Societies in Germany and the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) process. A rigorous and transparent process included synthesis of relevant research in two commissioned systematic reviews, evaluation of the quality and strength of evidence, formulation of specific recommendations and a structured consensus process involving leading experts and a broad base of stakeholders. Recommendations were based on the best available evidence, combined with structured expert consensus, particularly in areas where direct evidence remains scarce. Results: The S2k‐level CPG for the management of acute periodontal conditions presents a structured approach, grouping the recommendations in three successive steps: (1) confirming diagnosis, following the case definitions of the 2018 classification; (2) initial treatment, to control the acute condition including pain and active tissue destruction; and (3) subsequent treatments, to manage the pre‐existing conditions and prevent the risk of disease recurrence and/or control the potential sequelae. Conclusion: The present S2k‐level CPG informs clinical practice, health systems, policymakers and, indirectly, the public on the available and most effective interventions in the management of acute periodontal conditions.
- 9 September 2026
- Published by Wiley in Journal of Clinical Periodontology
Management of Acute Periodontal Conditions—The EFP S2k Level Clinical Practice Guideline
Background: The European Federation of Periodontology (EFP) has developed Clinical Practice Guidelines (CPGs) for the treatment of periodontitis and for the management of peri‐implant diseases. In accordance with the 2018 Classification, acute periodontal conditions are characterised by rapid‐onset pain or discomfort, tissue destruction and infection. Therefore, the development of a CPG to guide patients and clinicians in their management is justified. Aim: To develop an S2k‐level CPG for the management of acute periodontal conditions, necrotising periodontal diseases, periodontal abscesses and acute manifestations of endodontic–periodontal lesions. Methods: This S2k‐level CPG was developed by the EFP, following methodological guidance from the Association of Scientific Medical Societies in Germany and the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) process. A rigorous and transparent process included synthesis of relevant research in two commissioned systematic reviews, evaluation of the quality and strength of evidence, formulation of specific recommendations and a structured consensus process involving leading experts and a broad base of stakeholders. Recommendations were based on the best available evidence, combined with structured expert consensus, particularly in areas where direct evidence remains scarce. Results: The S2k‐level CPG for the management of acute periodontal conditions presents a structured approach, grouping the recommendations in three successive steps: (1) confirming diagnosis, following the case definitions of the 2018 classification; (2) initial treatment, to control the acute condition including pain and active tissue destruction; and (3) subsequent treatments, to manage the pre‐existing conditions and prevent the risk of disease recurrence and/or control the potential sequelae. Conclusion: The present S2k‐level CPG informs clinical practice, health systems, policymakers and, indirectly, the public on the available and most effective interventions in the management of acute periodontal conditions.
- Open Access
- 25 August 2026
- Published by Elsevier in Journal of Dentistry
- Vol. 176
Root canal treatment vs implants: Survival and costs in a national cohort
- 25 August 2026
- Published by Elsevier in Journal of Dentistry
- Vol. 176
Open AccessRoot canal treatment vs implants: Survival and costs in a national cohort
- 28 June 2026
- Published by Wiley in Clinical Oral Implants Research
- Vol. 37 (9) , 1109-1117
Adjunctive Electrolytic Implant Surface Decontamination in the Reconstructive Surgical Treatment of Peri‐Implantitis—A Randomized Clinical Trial
Objectives: The aim of this study was to evaluate the adjunctive effect of electrolytic cleaning in the surgical treatment of peri‐implantitis. Materials and Methods: A total of 40 patients (44 implants) with peri‐implantitis‐associated intra‐bony defects were included in this single‐center randomized controlled trial. Surgical decontamination of implant surfaces was initiated by use of a rotating titanium brush. Following random allocation, adjunctive electrolytic cleaning was performed in the test group. Xenogeneic bone substitute and a resorbable collagen membrane were then used in both groups. Clinical parameters including probing pocket depth (PPD), bleeding/suppuration on probing, buccal mucosal recession (REC), and keratinized mucosa were assessed at 6 and 12 months. Radiographic marginal bone levels (MBL) and patient‐reported outcomes (PROs) were evaluated at 12 months. The primary outcome was a composite measure including implant survival, complete absence of BoP/SoP, PPD ≤ 5 mm and REC ≤ 1 mm at 12 months. Results: At 12 months, no implants were lost. The composite outcome was complete at 27.3% of control and 40.0% of test implants ( p = 0.41 ). Mean PPD reductions were 4.5 ± 2.6 mm (control) and 3.8 ± 2.3 mm (test), while MBL gains were 1.9 ± 2.4 mm and 2.1 ± 2.0 mm, respectively. No significant intergroup differences were observed for any clinical, radiographic or PROs. Post‐surgical complications occurred in the test group. Conclusions: Clinical, radiographic and patient‐reported outcomes of surgical therapy of peri‐implantitis were favorable at 12 months. The adjunctive use of electrolytic cleaning provided no added benefit over the use of a rotating titanium brush alone. Trial Registration: ISRCTN17197337 (ISRCTN)
- 28 June 2026
- Published by Wiley in Clinical Oral Implants Research
- Vol. 37 (9) , 1109-1117
Adjunctive Electrolytic Implant Surface Decontamination in the Reconstructive Surgical Treatment of Peri‐Implantitis—A Randomized Clinical Trial
Objectives: The aim of this study was to evaluate the adjunctive effect of electrolytic cleaning in the surgical treatment of peri‐implantitis. Materials and Methods: A total of 40 patients (44 implants) with peri‐implantitis‐associated intra‐bony defects were included in this single‐center randomized controlled trial. Surgical decontamination of implant surfaces was initiated by use of a rotating titanium brush. Following random allocation, adjunctive electrolytic cleaning was performed in the test group. Xenogeneic bone substitute and a resorbable collagen membrane were then used in both groups. Clinical parameters including probing pocket depth (PPD), bleeding/suppuration on probing, buccal mucosal recession (REC), and keratinized mucosa were assessed at 6 and 12 months. Radiographic marginal bone levels (MBL) and patient‐reported outcomes (PROs) were evaluated at 12 months. The primary outcome was a composite measure including implant survival, complete absence of BoP/SoP, PPD ≤ 5 mm and REC ≤ 1 mm at 12 months. Results: At 12 months, no implants were lost. The composite outcome was complete at 27.3% of control and 40.0% of test implants ( p = 0.41 ). Mean PPD reductions were 4.5 ± 2.6 mm (control) and 3.8 ± 2.3 mm (test), while MBL gains were 1.9 ± 2.4 mm and 2.1 ± 2.0 mm, respectively. No significant intergroup differences were observed for any clinical, radiographic or PROs. Post‐surgical complications occurred in the test group. Conclusions: Clinical, radiographic and patient‐reported outcomes of surgical therapy of peri‐implantitis were favorable at 12 months. The adjunctive use of electrolytic cleaning provided no added benefit over the use of a rotating titanium brush alone. Trial Registration: ISRCTN17197337 (ISRCTN)
- Open Access
- 24 April 2026
- Published by Wiley in Periodontology 2000
Marginal bone loss around implants – What does it mean?
Background: Changes in peri‐implant marginal bone levels (MBL) constitute a central outcome in studies on implant therapy and reflect the integrity of the supporting tissues over time. Aim: To summarize current evidence on MBL changes around dental implants, with emphasis on temporal patterns, methods of assessment and their clinical interpretation. Materials and Methods: This narrative review is based on a targeted screening of the literature, including pre‐clinical investigations, observational studies and clinical trials reporting radiographically assessed MBL changes. Population‐based datasets and randomized controlled trials were prioritized. Results: The available evidence indicates that most MBL change occurs during the early phases following implant installation and abutment connection and typically does not exceed 1 mm, reflecting physiological remodeling. After prosthetic loading, further MBL alterations are generally also limited, commonly within a range of 0.1–0.3 mm during the first year of function and minimal changes thereafter. Radiographic methods are most frequently used for MBL assessment, with reported measurement errors in the order of ≤0.5 mm. While mean MBL changes are small in most studies, analyses of distributions show that approximately 15–25% of implants present with bone loss exceeding 1 mm, whereas only a smaller proportion exhibits pronounced bone loss. Conclusions: MBL changes over time are limited at the majority of dental implants. These alterations represent the cumulative effects of biological, mechanical and host‐related factors. The interpretation of MBL changes should consider methodological aspects of assessment and reporting, as well as their relationship to peri‐implant diseases. Progressive bone loss constitutes a defining feature of peri‐implantitis.
- 24 April 2026
- Published by Wiley in Periodontology 2000
Open AccessMarginal bone loss around implants – What does it mean?
Background: Changes in peri‐implant marginal bone levels (MBL) constitute a central outcome in studies on implant therapy and reflect the integrity of the supporting tissues over time. Aim: To summarize current evidence on MBL changes around dental implants, with emphasis on temporal patterns, methods of assessment and their clinical interpretation. Materials and Methods: This narrative review is based on a targeted screening of the literature, including pre‐clinical investigations, observational studies and clinical trials reporting radiographically assessed MBL changes. Population‐based datasets and randomized controlled trials were prioritized. Results: The available evidence indicates that most MBL change occurs during the early phases following implant installation and abutment connection and typically does not exceed 1 mm, reflecting physiological remodeling. After prosthetic loading, further MBL alterations are generally also limited, commonly within a range of 0.1–0.3 mm during the first year of function and minimal changes thereafter. Radiographic methods are most frequently used for MBL assessment, with reported measurement errors in the order of ≤0.5 mm. While mean MBL changes are small in most studies, analyses of distributions show that approximately 15–25% of implants present with bone loss exceeding 1 mm, whereas only a smaller proportion exhibits pronounced bone loss. Conclusions: MBL changes over time are limited at the majority of dental implants. These alterations represent the cumulative effects of biological, mechanical and host‐related factors. The interpretation of MBL changes should consider methodological aspects of assessment and reporting, as well as their relationship to peri‐implant diseases. Progressive bone loss constitutes a defining feature of peri‐implantitis.
- Open Access
- 17 February 2026
- Published by Springer Nature in BDJ Open
- Vol. 12 (1) , 18
Association between subclinical coronary artery atherosclerosis and oral health—a study on a Swedish population
Introduction: Oral health has been linked to cardiovascular disease (CVD), but its relationship to subclinical coronary artery atherosclerosis (SCAA) remains unclear. Using coronary computed tomography angiography (CCTA), we explored this association in an asymptomatic population. Material and method: A total of 410 non-smokers (193 women, mean age: 64.6 years), comprising 204 individuals with SCAA and 206 without (non-SCAA), were assessed through clinical and radiographic oral evaluations. Self-reported oral symptoms were scored by questionnaire. We used sex-stratified regression analysis and compared model performance with and without the addition of data on oral health through area under the curve (AUC). The reference model included age and history of smoking. Results: Individuals with SCAA had more missing teeth, higher Decayed and Filled Teeth scores and greater prevalence of peri-apical lesions and marginal bone loss >33%. Missing teeth was an independent risk indicator for SCAA (OR 1.15 95%CI 1.04–1.27). Model performance improved with the addition of oral status and self-reported oral symptoms, most prominently in women (AUC 0.67 vs. 0.78, p = 0.010). Decision curve analyses confirmed a consistent net benefit when data on oral health were considered. Conclusions: The findings suggest that subclinical coronary artery atherosclerosis is associated with oral health. Oral health-related data may improve screening for risk of coronary events, especially in women.
- 17 February 2026
- Published by Springer Nature in BDJ Open
- Vol. 12 (1) , 18
Open AccessAssociation between subclinical coronary artery atherosclerosis and oral health—a study on a Swedish population
Introduction: Oral health has been linked to cardiovascular disease (CVD), but its relationship to subclinical coronary artery atherosclerosis (SCAA) remains unclear. Using coronary computed tomography angiography (CCTA), we explored this association in an asymptomatic population. Material and method: A total of 410 non-smokers (193 women, mean age: 64.6 years), comprising 204 individuals with SCAA and 206 without (non-SCAA), were assessed through clinical and radiographic oral evaluations. Self-reported oral symptoms were scored by questionnaire. We used sex-stratified regression analysis and compared model performance with and without the addition of data on oral health through area under the curve (AUC). The reference model included age and history of smoking. Results: Individuals with SCAA had more missing teeth, higher Decayed and Filled Teeth scores and greater prevalence of peri-apical lesions and marginal bone loss >33%. Missing teeth was an independent risk indicator for SCAA (OR 1.15 95%CI 1.04–1.27). Model performance improved with the addition of oral status and self-reported oral symptoms, most prominently in women (AUC 0.67 vs. 0.78, p = 0.010). Decision curve analyses confirmed a consistent net benefit when data on oral health were considered. Conclusions: The findings suggest that subclinical coronary artery atherosclerosis is associated with oral health. Oral health-related data may improve screening for risk of coronary events, especially in women.
- 3 November 2025
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 53 (2) , 268-285
The Use of a Resorbable Membrane as an Adjunct to a Xenogeneic Bone Replacement Graft in the Reconstructive Surgical Therapy of Peri‐Implantitis: 3‐Year Results of a Randomised Clinical Trial
Aim: To evaluate the effect of the adjunctive use of a resorbable collagen membrane in the reconstructive surgical therapy of peri‐implantitis. Material and Methods: Forty‐three patients (43 implants) diagnosed with peri‐implantitis underwent surgical treatment using a reconstructive approach, which included a bone substitute material with (test) or without (control) a resorbable collagen membrane. Supportive peri‐implant treatment was administered biannually during the 3‐year follow‐up period. Clinical outcomes, such as probing pocket depth (PPD), bleeding on probing (BOP), suppuration on probing (SOP), marginal mucosal level (REC) and keratinised mucosa width (KM), were recorded at baseline, as well as at 6, 12 and 36 months. Radiographic marginal bone levels (MBLs) and patient‐reported outcomes (PROs) were also evaluated. The primary outcome was a composite measure consisting of PPD ≤ 5 mm, absence of BOP/SOP and buccal REC of ≤ 1 mm. A second composite outcome, termed ‘disease resolution’, was also assessed, defined as PPD ≤ 5 mm, BOP at ≤ 1 site and complete absence of SOP. Results: Out of the 43 participants, 8 were lost to follow‐up, 2 experienced implant loss and 1 was surgically re‐treated. At 3 years, the composite outcome was achieved for 25.0% of implants (test: 17.6%; control: 27.8%), while disease resolution was achieved for 31.2% (test: 29.4%; control: 27.8%). Overall, PPD and BOP were reduced by 3.6 ± 3.2 mm and 37.5% ± 42.1%, respectively. Changes in buccal REC and KM were 0.5 ± 1.3 and 1.1 ± 1.5 mm, respectively. An overall bone gain (MBL change) of 1.0 ± 2.2 mm was observed. PROs were favourable. No statistically significant differences were observed between groups. Conclusion: Adding a collagen membrane to a bone substitute material in the surgical treatment of peri‐implantitis did not yield any benefits regarding clinical, radiographic or patient‐reported outcomes. Trial Registration: ISRCTN67095066 ( https://www.isrctn.com/ISRCTN67095066 )
- 3 November 2025
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 53 (2) , 268-285
The Use of a Resorbable Membrane as an Adjunct to a Xenogeneic Bone Replacement Graft in the Reconstructive Surgical Therapy of Peri‐Implantitis: 3‐Year Results of a Randomised Clinical Trial
Aim: To evaluate the effect of the adjunctive use of a resorbable collagen membrane in the reconstructive surgical therapy of peri‐implantitis. Material and Methods: Forty‐three patients (43 implants) diagnosed with peri‐implantitis underwent surgical treatment using a reconstructive approach, which included a bone substitute material with (test) or without (control) a resorbable collagen membrane. Supportive peri‐implant treatment was administered biannually during the 3‐year follow‐up period. Clinical outcomes, such as probing pocket depth (PPD), bleeding on probing (BOP), suppuration on probing (SOP), marginal mucosal level (REC) and keratinised mucosa width (KM), were recorded at baseline, as well as at 6, 12 and 36 months. Radiographic marginal bone levels (MBLs) and patient‐reported outcomes (PROs) were also evaluated. The primary outcome was a composite measure consisting of PPD ≤ 5 mm, absence of BOP/SOP and buccal REC of ≤ 1 mm. A second composite outcome, termed ‘disease resolution’, was also assessed, defined as PPD ≤ 5 mm, BOP at ≤ 1 site and complete absence of SOP. Results: Out of the 43 participants, 8 were lost to follow‐up, 2 experienced implant loss and 1 was surgically re‐treated. At 3 years, the composite outcome was achieved for 25.0% of implants (test: 17.6%; control: 27.8%), while disease resolution was achieved for 31.2% (test: 29.4%; control: 27.8%). Overall, PPD and BOP were reduced by 3.6 ± 3.2 mm and 37.5% ± 42.1%, respectively. Changes in buccal REC and KM were 0.5 ± 1.3 and 1.1 ± 1.5 mm, respectively. An overall bone gain (MBL change) of 1.0 ± 2.2 mm was observed. PROs were favourable. No statistically significant differences were observed between groups. Conclusion: Adding a collagen membrane to a bone substitute material in the surgical treatment of peri‐implantitis did not yield any benefits regarding clinical, radiographic or patient‐reported outcomes. Trial Registration: ISRCTN67095066 ( https://www.isrctn.com/ISRCTN67095066 )
- Open Access
- 24 October 2025
- Published by Wiley in Clinical Oral Implants Research
- Vol. 37 (2) , 224-233
Dental Research in the Digital Age: The Registry‐Based Clinical Trial
With the global increase in the volume of digital health data recorded and accessible through national and institutional databases, such as clinical registries and evidence‐based registries, new strategic approaches are now feasible in medical research. These approaches include the registry‐based clinical trial (RBCT) design, where large‐scale datasets—which grow exponentially over time (referred to as big data)—can be used to identify eligible study participants from a medical registry containing trial‐specific inclusion criteria. The RBCT approach may also be used to establish historical control groups for prospective interventional studies that enable rapid recruitment with a lower study budget, while providing high statistical power. Hence, obstacles frequently encountered when conducting randomized controlled trials, such as difficulties in recruiting a sufficient sample size in a reasonable time period, may be overcome for specific research questions. This innovative study design of an RBCT aims to combine the external validity of medical registries with the internal validity of the traditional study designs, and has the potential to influence clinical decision making and healthcare policy. The aim of this perspective article is to describe this new methodological approach and to critically analyze the future possibilities and challenges of RBCTs in dental and implant research.
- 24 October 2025
- Published by Wiley in Clinical Oral Implants Research
- Vol. 37 (2) , 224-233
Open AccessDental Research in the Digital Age: The Registry‐Based Clinical Trial
With the global increase in the volume of digital health data recorded and accessible through national and institutional databases, such as clinical registries and evidence‐based registries, new strategic approaches are now feasible in medical research. These approaches include the registry‐based clinical trial (RBCT) design, where large‐scale datasets—which grow exponentially over time (referred to as big data)—can be used to identify eligible study participants from a medical registry containing trial‐specific inclusion criteria. The RBCT approach may also be used to establish historical control groups for prospective interventional studies that enable rapid recruitment with a lower study budget, while providing high statistical power. Hence, obstacles frequently encountered when conducting randomized controlled trials, such as difficulties in recruiting a sufficient sample size in a reasonable time period, may be overcome for specific research questions. This innovative study design of an RBCT aims to combine the external validity of medical registries with the internal validity of the traditional study designs, and has the potential to influence clinical decision making and healthcare policy. The aim of this perspective article is to describe this new methodological approach and to critically analyze the future possibilities and challenges of RBCTs in dental and implant research.
- Open Access
- 21 October 2025
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 53 (2) , 244-255
Implantoplasty vs. Rotating Titanium Brushes in the Surgical Treatment of Peri‐Implantitis: A 1‐Year Randomised Controlled Clinical Trial
Aim: To evaluate treatment outcomes following implantoplasty or the use of rotating titanium brushes in the surgical therapy of peri‐implantitis. Materials and Methods: Thirty patients with peri‐implantitis in need of surgical treatment were enrolled in a 12‐month randomised clinical trial with a non‐inferiority set‐up. Surface decontamination was performed using either titanium brushes (test group) or implantoplasty (control group). Clinical and radiographic parameters as well as patient‐reported outcomes (Oral Health Impact Profile‐14; OHIP‐14) were evaluated. Results: At 12 months, the composite outcome was achieved in 6/15 implants in the test group and in 4/15 in the control group. Probing pocket depth (PPD) values decreased by 3.6 ± 1.5 mm (test) and 3.3 ± 1.2 mm (control), demonstrating non‐inferiority of the test procedure. Additional bone loss was observed in the control group (0.7 ± 1.2 mm), while bone levels remained unchanged in the test group (0.0 ± 0.6 mm). Baseline PPD ( p = 0.044) and the presence of an adjacent implant affected by peri‐implantitis ( p = 0.033) were relevant factors for pocket closure (PPD ≤ 5 mm at 12 months). Time for surface decontamination was significantly less in the test (3 min 1 s) when compared to the control group (5 min 27 s) ( p = 0.006). OHIP‐14 scores were statistically indifferent. Conclusion: Both groups showed favourable outcomes, demonstrating non‐inferiority of titanium brushes to implantoplasty. Trial Registration: The trial was registered with the Clinical Research Information Service of the National Research Institute of Health (South Korea), no. KCT007900. ( https://cris.nih.go.kr/cris/search/detailSearch.do?seq=23346&search_page=L )
- 21 October 2025
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 53 (2) , 244-255
Open AccessImplantoplasty vs. Rotating Titanium Brushes in the Surgical Treatment of Peri‐Implantitis: A 1‐Year Randomised Controlled Clinical Trial
Aim: To evaluate treatment outcomes following implantoplasty or the use of rotating titanium brushes in the surgical therapy of peri‐implantitis. Materials and Methods: Thirty patients with peri‐implantitis in need of surgical treatment were enrolled in a 12‐month randomised clinical trial with a non‐inferiority set‐up. Surface decontamination was performed using either titanium brushes (test group) or implantoplasty (control group). Clinical and radiographic parameters as well as patient‐reported outcomes (Oral Health Impact Profile‐14; OHIP‐14) were evaluated. Results: At 12 months, the composite outcome was achieved in 6/15 implants in the test group and in 4/15 in the control group. Probing pocket depth (PPD) values decreased by 3.6 ± 1.5 mm (test) and 3.3 ± 1.2 mm (control), demonstrating non‐inferiority of the test procedure. Additional bone loss was observed in the control group (0.7 ± 1.2 mm), while bone levels remained unchanged in the test group (0.0 ± 0.6 mm). Baseline PPD ( p = 0.044) and the presence of an adjacent implant affected by peri‐implantitis ( p = 0.033) were relevant factors for pocket closure (PPD ≤ 5 mm at 12 months). Time for surface decontamination was significantly less in the test (3 min 1 s) when compared to the control group (5 min 27 s) ( p = 0.006). OHIP‐14 scores were statistically indifferent. Conclusion: Both groups showed favourable outcomes, demonstrating non‐inferiority of titanium brushes to implantoplasty. Trial Registration: The trial was registered with the Clinical Research Information Service of the National Research Institute of Health (South Korea), no. KCT007900. ( https://cris.nih.go.kr/cris/search/detailSearch.do?seq=23346&search_page=L )
- Open Access
- 28 August 2025
- Published by Wiley in Clinical Oral Implants Research
- Vol. 36 (12) , 1560-1574
Clinical Trends in the Prevention of Peri‐Implantitis: Spanish Society of Periodontology ( SEPA) Foundation Survey Using the Delphi Method
Objective: To assess clinical trends to prevent peri‐implantitis in applying a two‐step survey based on the Delphi method. Material and Methods: A panel of participants aged < 45 years old selected by the Spanish Society of Periodontology (SEPA) was asked to answer a survey with 75 statements prepared by a steering committee. Items were divided into 5 major areas: etiopathogenesis and epidemiology, surgical, implant, and prosthetic‐related factors on the onset/progression of peri‐implantitis, and self‐ and professional‐administered oral hygiene. Degree of agreement or disagreement among participants was reported. Results: In total, 44 participants responded favorably to participate in the survey. From the 75 statements formulated, 35 were agreed on in a first round (46.7%). From the 40 statements that did not reach consensus, 16 were agreed on in a second round (40.0%). Overall, 51 out of 75 statements (68.0%) achieved consensus in a second round. From these, 36 (48.0%) were in agreement, while 15 (20.0%) were in disagreement. The sections that explored surgical‐related factors and prosthesis‐related factors of peri‐implantitis yielded the highest level of conflict (9/18 and 8/14 statements demonstrated indeterminate agreement, respectively). In the sections on the etiopathogenesis and epidemiology of peri‐implantitis and implant‐related factors, most items reached consensus (14/17 and 10/13 items, respectively). The section on self‐ and professional‐administered oral hygiene obtained the highest level of consensus, with only 1/13 items showing dissent among the participants. Conclusion: The results of this study on the clinical trends in the prevention of peri‐implantitis showed consensus agreement for ∼70% of the statements evaluated.
- 28 August 2025
- Published by Wiley in Clinical Oral Implants Research
- Vol. 36 (12) , 1560-1574
Open AccessClinical Trends in the Prevention of Peri‐Implantitis: Spanish Society of Periodontology ( SEPA) Foundation Survey Using the Delphi Method
Objective: To assess clinical trends to prevent peri‐implantitis in applying a two‐step survey based on the Delphi method. Material and Methods: A panel of participants aged < 45 years old selected by the Spanish Society of Periodontology (SEPA) was asked to answer a survey with 75 statements prepared by a steering committee. Items were divided into 5 major areas: etiopathogenesis and epidemiology, surgical, implant, and prosthetic‐related factors on the onset/progression of peri‐implantitis, and self‐ and professional‐administered oral hygiene. Degree of agreement or disagreement among participants was reported. Results: In total, 44 participants responded favorably to participate in the survey. From the 75 statements formulated, 35 were agreed on in a first round (46.7%). From the 40 statements that did not reach consensus, 16 were agreed on in a second round (40.0%). Overall, 51 out of 75 statements (68.0%) achieved consensus in a second round. From these, 36 (48.0%) were in agreement, while 15 (20.0%) were in disagreement. The sections that explored surgical‐related factors and prosthesis‐related factors of peri‐implantitis yielded the highest level of conflict (9/18 and 8/14 statements demonstrated indeterminate agreement, respectively). In the sections on the etiopathogenesis and epidemiology of peri‐implantitis and implant‐related factors, most items reached consensus (14/17 and 10/13 items, respectively). The section on self‐ and professional‐administered oral hygiene obtained the highest level of consensus, with only 1/13 items showing dissent among the participants. Conclusion: The results of this study on the clinical trends in the prevention of peri‐implantitis showed consensus agreement for ∼70% of the statements evaluated.